We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
Register to vote Register by 18 June to vote in the General Election on 4 July.
Did you mean reduces cholesterol
Legal standards for labelling and composition of food products such as bottled water, milk and meat.
Explains how commissioners and health professionals can use data and analysis for decisions about cardiovascular services and interventions.
Information about the risks of taking valproate medicines during pregnancy.
Find out about green taxes for businesses - tax relief for becoming more energy efficient and schemes for off-setting your environmental impact
How costs to the consumer are affected by changes in energy and climate change policy.
The review of the safety of isotretinoin has concluded.
This document explains the NHS view on private screening for different conditions and diseases.
The MHRA has authorised cabotegravir as 30 mg tablets and as a 600 mg long-acting injection administered every two months
Information and guidance on a range of medical devices for users and patients.
Information for healthcare professionals on how pulse oximeters are regulated, home use and issues to look out for when using the devices
Government outlines action to make UK a world leader in tackling ethnic and other biases in medical devices.
Advice and guidance on the health needs of migrant patients from Estonia for healthcare practitioners.
Get help to classify pharmaceutical products used to treat or prevent diseases or ailments (in humans or animals), including comparators used in clinical trials and placebos.
Additional tests for passenger vehicles - Low Emissions Certificate and seat belt installation tests
Government incentives for CHP schemes
The Medicines and Healthcare products Regulatory Agency (MHRA) has today (11 March 2024) approved the medicine etrasimod (Velsipity) to treat people with moderately to severely active ulcerative colitis.
Outlines the provisions of the Food (Promotion and Placement) (England) Regulations 2021, and provides assistance in understanding and applying them.
How much PE and sport premium funding schools will receive for the academic year 2023 to 2024 and advice on how to spend it.
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. Please fill in this survey (opens in a new tab).